Life with Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation: New Treatment Approaches

Listen Now

Topics Covered

• What is Graft vs. Host Disease (GVHD) Post Allogeneic Stem Cell or Bone Marrow Transplantation?
• Understanding How GVHD Develops
• Finding GVHD Early, in the Context of COVID-19
• Common Signs & Symptoms of GVHD
• Types of GVHD: Chronic and Acute
• Current Standard of Care for Managing GVHD
• New & Promising Treatment Approaches for GVHD
• Clinical Trials Updates
• How Research Increases Treatment Options
• Key Questions to Ask Your Health Care Team about GVHD
• Follow-Up Care Appointments
• Communicating with Your Health Care Team about Your Quality-of-Life Concerns
• Guidelines to Prepare for Telehealth/Telemedicine Appointment, including Technology & List of Questions
• Questions for Our Panel of Experts

Our Panel of Experts

Yi-Bin Chen, MD, MS

Director, Hematopoietic Cell Transplant & Cell Therapy Program, Cara J. Rogers Endowed Scholar, Massachusetts General Hospital, Associate Professor of Medicine, Harvard Medical School

Markus Y. Mapara, MD, PhD

Professor of Medicine, Columbia University Medical Center, Director, Bone Marrow Transplantation and Cell Therapy Program, College of Physicians and Surgeons

Carolyn Messner, DSW, BCD, FAPOS, FAOSW

Director of Education and Training, CancerCare

Brochure

You can download the brochure for this workshop

Workshop Date

This workshop was originally recorded on May 13, 2021.